Exercise and drug combo may fight fatigue in rare disease
NCT ID NCT07444333
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether doing aerobic exercise at home, with or without the drug omaveloxolone, can safely improve fatigue and heart-lung fitness in people with Friedreich's ataxia. About 30 adults with the condition will take part. The goal is to see if the combination helps them feel less tired and move better.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRIEDREICH'S ATAXIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can advanced heart scans predict the biggest killer in Friedreich's ataxia?
- Experimental drug aims to halt rare neurological decline
- New brain scans could reveal hidden clues in rare nerve disease
- Genetic clues may predict when Friedreich's ataxia begins
- Can a supplement and exercise improve stamina in Friedreich's ataxia?
- New study aims to uncover hidden clues in Friedreich's ataxia